Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VWF anticorps (AA 1815-1939)

L’anticorps Souris Monoclonal anti-VWF a été validé pour WB et IHC (f). Il convient pour détecter VWF dans des échantillons de Humain.
N° du produit ABIN6938775

Aperçu rapide pour VWF anticorps (AA 1815-1939) (ABIN6938775)

Antigène

Voir toutes VWF Anticorps
VWF (Von Willebrand Factor (VWF))

Reactivité

  • 191
  • 38
  • 28
  • 7
  • 6
  • 5
  • 1
  • 1
Humain

Hôte

  • 105
  • 105
  • 13
  • 7
  • 1
  • 1
  • 1
Souris

Clonalité

  • 128
  • 100
  • 2
Monoclonal

Conjugué

  • 104
  • 25
  • 15
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp VWF est non-conjugé

Application

  • 140
  • 138
  • 77
  • 61
  • 57
  • 46
  • 31
  • 28
  • 25
  • 16
  • 16
  • 15
  • 9
  • 9
  • 7
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

VWF-1465
  • Épitope

    • 52
    • 21
    • 16
    • 10
    • 7
    • 6
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1815-1939

    Specificité

    Von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant fragment of human vWF protein (aa1815-1939) (exact sequence is proprietary)

    Isotype

    IgG1 kappa
  • Indications d'application

    Known_Application: Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT) (Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: HUVEC cells. Tonsil.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    VWF (Von Willebrand Factor (VWF))

    Autre désignation

    VWF

    Sujet

    Coagulation Factor VIII, Factor VIII Related Antigen, F8VWF, von Willebrand Antigen 2, von Willebrand Disease (vWD),von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker)
    Cellular localisation: Cytoplasmic

    Poids moléculaire

    250kDa

    ID gène

    7450, 440848

    UniProt

    P04275
Vous êtes ici:
Chat with us!